Population pharmacokinetic study and application of ticagrelor and AR-C124910XX after percutaneous coronary intervention in Chinese patients with acute coronary syndrome
Int. Journal of Clinical Pharmacology and Therapeutics · 2024
DOI: 10.5414/cp204550 ↗Kurz gefasst
Fachartikel in der Zeitschrift Int. Journal of Clinical Pharmacology and Therapeutics, 2024. Verfasst von Meng Liu und 5 weiteren Autor:innen. Hauptthemen laut MEDLINE: Ticagrelor, Acute Coronary Syndrome, Percutaneous Coronary Intervention. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Liu, M., Qin, J., Chu, X., Chen, N., Jie, Q., & Zheng, S. (2024). Population pharmacokinetic study and application of ticagrelor and AR-C124910XX after percutaneous coronary intervention in Chinese patients with acute coronary syndrome. Int. Journal of Clinical Pharmacology and Therapeutics. https://doi.org/10.5414/cp204550
Vancouver
Liu M, Qin J, Chu X, Chen N, Jie Q, Zheng S. Population pharmacokinetic study and application of ticagrelor and AR-C124910XX after percutaneous coronary intervention in Chinese patients with acute coronary syndrome. Int. Journal of Clinical Pharmacology and Therapeutics. 2024. doi:10.5414/cp204550
BibTeX
@article{Liu2024,
author = {Liu, Meng and Qin, Jun and Chu, XiaoQian and Chen, NaiDong and Jie, Qiong and Zheng, ShaoJun},
title = {Population pharmacokinetic study and application of ticagrelor and AR-C124910XX after percutaneous coronary intervention in Chinese patients with acute coronary syndrome},
journal = {Int. Journal of Clinical Pharmacology and Therapeutics},
year = {2024},
doi = {10.5414/cp204550}
}
EUVIMED